Surgical Science Sweden Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 6/6
Surgical Science Sweden hat ein Gesamteigenkapital von SEK4.6B und eine Gesamtverschuldung von SEK0.0, wodurch sich der Verschuldungsgrad auf 0% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen SEK5.0B bzw. SEK370.8M. Surgical Science Sweden Das EBIT des Unternehmens beträgt SEK164.4M, so dass der Zinsdeckungsgrad -42.6 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von SEK659.2M.
Wichtige Informationen
0%
Verhältnis von Schulden zu Eigenkapital
SEK 0
Verschuldung
| Zinsdeckungsgrad | -17.1x |
| Bargeld | SEK 667.08m |
| Eigenkapital | SEK 4.59b |
| Gesamtverbindlichkeiten | SEK 369.72m |
| Gesamtvermögen | SEK 4.96b |
Jüngste Berichte zur Finanzlage
Keine Aktualisierungen
Recent updates
Surgical Science Sweden AB (publ) Just Missed EPS By 22%: Here's What Analysts Think Will Happen Next
Aug 25
Earnings Beat: Surgical Science Sweden AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 21Here's Why Surgical Science Sweden (STO:SUS) Has Caught The Eye Of Investors
Apr 16Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Is Still Matching Investor Opinion Despite 25% Slump
Mar 17Results: Surgical Science Sweden AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts
Feb 24Is There Now An Opportunity In Surgical Science Sweden AB (publ) (STO:SUS)?
Nov 29Should You Be Adding Surgical Science Sweden (STO:SUS) To Your Watchlist Today?
Oct 07Is Surgical Science Sweden AB (publ) (STO:SUS) Trading At A 39% Discount?
Aug 17With EPS Growth And More, Surgical Science Sweden (STO:SUS) Makes An Interesting Case
Jun 20A Look At The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)
May 17Surgical Science Sweden AB (publ) (STO:SUS) Shares Could Be 49% Below Their Intrinsic Value Estimate
Dec 27Is Now The Time To Put Surgical Science Sweden (STO:SUS) On Your Watchlist?
Dec 06Is Now The Time To Look At Buying Surgical Science Sweden AB (publ) (STO:SUS)?
Sep 08We Ran A Stock Scan For Earnings Growth And Surgical Science Sweden (STO:SUS) Passed With Ease
Aug 23Surgical Science Sweden AB (publ) (STO:SUS) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless
May 26Here's Why We Think Surgical Science Sweden (STO:SUS) Is Well Worth Watching
Apr 29An Intrinsic Calculation For Surgical Science Sweden AB (publ) (STO:SUS) Suggests It's 44% Undervalued
Feb 20Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?
Jan 11Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?
Dec 15Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)
Sep 16Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?
Jul 05Calculating The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)
Jun 08Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?
Mar 23Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)
Mar 02Is Surgical Science Sweden AB (publ)'s (STO:SUS) Shareholder Ownership Skewed Towards Insiders?
Feb 09
Surgical Science Sweden AB (publ)'s (STO:SUS) Stock Is Going Strong: Have Financials A Role To Play?
Jan 01What Does Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Indicate?
Dec 14Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?
Nov 26Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: SUSDie kurzfristigen Aktiva des Unternehmens (SEK1.0B) übersteigen seine kurzfristigen Passiva (SEK247.7M).
Langfristige Verbindlichkeiten: SUSDie kurzfristigen Vermögenswerte des Unternehmens (SEK1.0B) übersteigen seine langfristigen Verbindlichkeiten (SEK123.1M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: SUS ist schuldenfrei.
Schulden abbauen: SUS hatte vor 5 Jahren keine Schulden.
Schuldendeckung: SUS hat keine Schulden und muss daher nicht durch den operativen Cashflow gedeckt werden.
Zinsdeckung: SUS hat keine Schulden, daher ist die Deckung der Zinszahlungen kein Problem.